Log In Get Started

News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • U.S. dollar steadies in Asian trading as markets await the two-day Federal Reserve meeting expected to hold rates unchanged.
  • Australian dollar weakens after March consumer inflation came in slightly below forecasts.
  • Regional Asian currencies soften amid renewed U.S.-Iran tensions.
  • Tesla plans international rollout of FSD V14 Lite following U.S. HW3 deployment.
  • Global primary tropical forest loss fell 36% in 2025 to 4.3 million hectares, led by Brazil's stronger anti-deforestation measures.
  • Powell appears set to relinquish the Fed chair, increasing market focus on Fed leadership changes.

Latest Articles

SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026
Mar 29, 2026
Ajmal Hussain
Press Releases

SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026

SeaStar Medical showcased new clinical data from its QUELIMMUNE SAVE Registry demonstrating no device-related adverse events and improved survival rates in pediatric patients with life-threatening Acute Kidney Injury (AKI). Additionally, mechanistic research highlighted how the Selective Cytopheretic Device (SCD) therapy modulates immune cells towa…

ICU
Jasper Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update
Mar 29, 2026
Hana Yamamoto
Press Releases

Jasper Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update

Jasper Therapeutics announced its Q4 and full-year 2025 financial results alongside significant clinical updates. The company reported positive data from its briquilimab studies targeting chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU), and asthma, highlighting rapid and durable disease control. They are finalizing dose sel…

JSPR
Village Farms Favorably Amends and Extends Farm Credit Canada Loan
Mar 29, 2026
Leila Farooq
Press Releases

Village Farms Favorably Amends and Extends Farm Credit Canada Loan

Village Farms International, Inc. announced a favorable amendment and extension of its Farm Credit Canada loan, reducing the interest rate by 50 basis points and extending the maturity to 2031. The company highlights its strong long-term partnership with FCC and signals confidence in sustained business growth for 2026. Village Farms is a leading gl…

VFF
SNDL Announces Leadership Transition for Cannabis Segment
Mar 29, 2026
Caleb Monroe
Press Releases

SNDL Announces Leadership Transition for Cannabis Segment

SNDL Inc., a major Canadian cannabis and liquor retailer listed on NASDAQ and CSE, announced that its President of Cannabis, Tyler Robson, has departed to pursue other opportunities. Ryan Hellard, the company's Chief Strategy Officer, will serve as Interim President of Cannabis as the company continues operations.

SNDL
Centerra Gold Announces Executive Changes
Mar 29, 2026
Derek Hwang
Press Releases

Centerra Gold Announces Executive Changes

Centerra Gold Inc. announced the departure of their Executive Vice President and COO, David Hendriks, who will stay on as a consultant during the transition. Mike Sylvestre, a veteran mining executive with over 45 years of experience, has been appointed interim COO. The company emphasized Sylvestre's operational expertise and leadership as they con…

CGAU
Artelo Biosciences Announces Closing of $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Mar 29, 2026
Caleb Monroe
Press Releases

Artelo Biosciences Announces Closing of $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Artelo Biosciences successfully closed an $11 million private placement by issuing common shares and warrants, with proceeds aimed at working capital, general corporate purposes, and debt repayment. The potential further proceeds of approximately $20.4 million could be realized if warrants are fully exercised. This financing enhances the company's …

ARTL
Lakeland Fire + Safety Completes Sale of HPFR and HiViz Product Line
Mar 29, 2026
Caleb Monroe
Press Releases

Lakeland Fire + Safety Completes Sale of HPFR and HiViz Product Line

Lakeland Industries, Inc. completed the sale of its High Performance Flame Resistant and High-Visibility product lines to National Safety Apparel, streamlining its portfolio to concentrate on its fire services and industrial PPE business. The divestiture enhances Lakeland's balance sheet and capital flexibility to invest in growth areas aligned wit…

LAKE
Lulus Reports Fourth Quarter and Fiscal Year 2025 Results
Mar 29, 2026
Nina Shah
Press Releases

Lulus Reports Fourth Quarter and Fiscal Year 2025 Results

Lulu's Fashion Lounge Holdings, Inc. reported improved financial results for Q4 and fiscal year 2025, highlighting a 200 bps increase in gross margin for the year, fourth quarter Adjusted EBITDA of $2.6 million, and a sharp reduction in net loss compared to 2024. Despite an 11% decline in full-year net revenue due to reduced order volume, the compa…

LVLU
Ultragenyx Announces FDA Clearance of Investigational New Drug (IND) Application for UX016, a Sialic Acid Prodrug for the Treatment of GNE Myopathy
Mar 29, 2026
Hana Yamamoto
Press Releases

Ultragenyx Announces FDA Clearance of Investigational New Drug (IND) Application for UX016, a Sialic Acid Prodrug for the Treatment of GNE Myopathy

Ultragenyx Pharmaceutical Inc. announced FDA clearance of its Investigational New Drug (IND) application for UX016, a sialic acid prodrug designed to treat GNE myopathy, a rare neuromuscular disorder. The clearance enables Ultragenyx to begin a Phase 1/2 clinical trial in the second half of 2026, with external patient group funding support. UX016 a…

RARE
Synergy CHC Corp. Announces Date Change of Fourth Quarter and Full Year 2025 Earnings and Conference Call
Mar 29, 2026
Leila Farooq
Press Releases

Synergy CHC Corp. Announces Date Change of Fourth Quarter and Full Year 2025 Earnings and Conference Call

Synergy CHC Corp., a consumer health and wellness company, announced its updated date for releasing fourth quarter and full year 2025 financial results on April 1, 2026, prior to market open. The company will host a live conference call with executives to discuss the results, accessible via webcast and phone. Synergy's leading brands include FOCUSf…

SNYR
Ero Files Technical Report for the Furnas Copper-Gold Project
Mar 29, 2026
Derek Hwang
Press Releases

Ero Files Technical Report for the Furnas Copper-Gold Project

Ero Copper Corp. announced the filing of a Technical Report supporting the Preliminary Economic Assessment (PEA) for its Furnas Copper-Gold Project in Pará State, Brazil. The report complies with Canadian regulatory standards and confirms progress in the company's earn-in agreement with Vale Base Metals to acquire a 60% interest in the project. Ero…

ERO
Genco Shipping & Trading Sends Letter to Shareholders
Mar 29, 2026
Marcus Reed
Press Releases

Genco Shipping & Trading Sends Letter to Shareholders

Genco Shipping & Trading Limited has issued a letter to shareholders defending its comprehensive value strategy, highlighting strong returns and operational performance over the past five years, while rejecting an acquisition proposal from competitor Diana Shipping as substantially undervaluing the company. Genco's board emphasizes its commitment t…

GNK
SS Innovations Expands Global Opportunity with Regulatory Approval of the SSi Mantra Surgical Robotic System in Colombia, Oman, Sri Lanka and Kenya
Mar 29, 2026
Avery Klein
Press Releases

SS Innovations Expands Global Opportunity with Regulatory Approval of the SSi Mantra Surgical Robotic System in Colombia, Oman, Sri Lanka and Kenya

SS Innovations International, Inc. announced the regulatory approval of its SSi Mantra surgical robotic system in Colombia, Oman, Sri Lanka, and Kenya. This expansion increases the company's presence in underpenetrated markets with its cost-effective advanced surgical technology. The company is also pursuing approvals in the US and EU, aiming to fu…

SSII
NewtekOne, Inc. to Report First Quarter 2026 Results and Host a Conference Call on Thursday, April 30, 2026
Mar 29, 2026
Ajmal Hussain
Press Releases

NewtekOne, Inc. to Report First Quarter 2026 Results and Host a Conference Call on Thursday, April 30, 2026

NewtekOne, Inc., a financial holding company offering diverse business and financial solutions, will release its first quarter 2026 financial results on April 30, 2026, after market close, accompanied by a conference call and webcast for investors and interested parties. The company serves independent business owners with offerings including bankin…

NEWT
AFC Expands Revolving Credit Facility with $30 Million Additional Commitment from Existing FDIC-Insured Banking Partner
Mar 29, 2026
Caleb Monroe
Press Releases

AFC Expands Revolving Credit Facility with $30 Million Additional Commitment from Existing FDIC-Insured Banking Partner

AFC has expanded its senior secured revolving credit facility by $30 million, increasing the total facility to $80 million with the potential to expand to $100 million. The additional funding will support AFC in providing flexible credit solutions to U.S. lower middle-market companies through loan origination and participation, supporting working c…

AFC
Nebius Dip: A Structured Long With a Tight Safety Net
Mar 29, 2026
Maya Rios
Trade Ideas

Nebius Dip: A Structured Long With a Tight Safety Net

Nebius (NBIS) is trading off a recent rally despite securing massive hyperscaler contracts and aggressively ramping GPU capacity. The setup favors a disciplined long: entry at $101, stop at $92, target $150. Balance the upside from a $49B contracted backlog and a $7-9B ARR pathway against execution, capital intensity, and short-volume pressure.

NBIS